Literature DB >> 10716254

Degeneration of the centré median-parafascicular complex in Parkinson's disease.

J M Henderson1, K Carpenter, H Cartwright, G M Halliday.   

Abstract

Two major noncortical inputs to the striatum originate from the substantia nigra and the thalamic centré median-parafascicular complex. Although it is established that in Parkinson's disease there is degeneration of the nigral dopaminergic neurons, there has been little analysis of the glutamatergic centré median-parafascicular complex. We therefore evaluated these and neighboring thalamic nuclei (for specificity of any changes) in 9 Parkinson's disease patients and 8 age-matched controls. Degeneration in the substantia nigra and centré median-parafascicular complex was estimated by using quantitative neuronal counts. On average, 70% of the pigmented nigral neurons degenerated and there was 30% to 40% neuronal loss in the centré median-parafascicular complex in Parkinson's disease. Thalamic degeneration was marked in neuronal subpopulations (50% loss of parvalbumin-positive neurons in the parafascicular, and 70% loss of non-parvalbumin-positive neurons in the centré median nuclei). In contrast, adjacent thalamic nuclei did not degenerate, which supports a selective neurodegeneration of the centré median-parafascicular complex. Our results show that the thalamic centré median-parafascicular complex is an additional nondopaminergic site of neurodegeneration in Parkinson's disease. Because this thalamic region provides important sensorimotor feedback to the striatum, degeneration of this region is likely to exacerbate the clinical signs and symptoms of Parkinson's disease.

Entities:  

Mesh:

Year:  2000        PMID: 10716254

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  68 in total

Review 1.  Thalamic contributions to Basal Ganglia-related behavioral switching and reinforcement.

Authors:  Yoland Smith; D James Surmeier; Peter Redgrave; Minoru Kimura
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

2.  The primate thalamostriatal systems: Anatomical organization, functional roles and possible involvement in Parkinson's disease.

Authors:  Adriana Galvan; Yoland Smith
Journal:  Basal Ganglia       Date:  2011-11-01

3.  Extracerebellar role for Cerebellin1: modulation of dendritic spine density and synapses in striatal medium spiny neurons.

Authors:  S V Kusnoor; J Parris; E C Muly; J I Morgan; A Y Deutch
Journal:  J Comp Neurol       Date:  2010-07-01       Impact factor: 3.215

4.  Loss of thalamic serotonin transporters in early drug-naïve Parkinson's disease patients is associated with tremor: an [(123)I]beta-CIT SPECT study.

Authors:  V Caretti; D Stoffers; A Winogrodzka; I-U Isaias; G Costantino; G Pezzoli; C Ferrarese; A Antonini; E-Ch Wolters; J Booij
Journal:  J Neural Transm (Vienna)       Date:  2008-03-12       Impact factor: 3.575

5.  Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys.

Authors:  Jose L Lanciego; Maria C Rodríguez-Oroz; Francisco J Blesa; Lydia Alvarez-Erviti; Jorge Guridi; Pedro Barroso-Chinea; Yoland Smith; Jose A Obeso
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

6.  Differences in excitatory transmission between thalamic and cortical afferents to single spiny efferent neurons of rat dorsal striatum.

Authors:  Roy M Smeal; Kristen A Keefe; Karen S Wilcox
Journal:  Eur J Neurosci       Date:  2008-11       Impact factor: 3.386

7.  Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms.

Authors:  Christian Pifl; Stephen J Kish; Oleh Hornykiewicz
Journal:  Mov Disord       Date:  2012-10-04       Impact factor: 10.338

8.  Effects of stimulation of the centromedian nucleus of the thalamus on the activity of striatal cells in awake rhesus monkeys.

Authors:  Bijli Nanda; Adriana Galvan; Yoland Smith; Thomas Wichmann
Journal:  Eur J Neurosci       Date:  2009-01-17       Impact factor: 3.386

Review 9.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

10.  Is the loss of thalamostriatal neurons protective in parkinsonism?

Authors:  Sheila V Kusnoor; E Chris Muly; James I Morgan; Ariel Y Deutch
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.